1 Commerce Place
Awapuni
Gisborne 4071
New Zealand
64 800 782 246
https://www.ruabio.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Panapa Ehau | Co-Founder & Executive Director | 45k | N/A | N/A |
Mr. Paul Naske | Chief Executive Officer | N/A | N/A | N/A |
Tony Robinson | Compliance & Business Development Manager | N/A | N/A | N/A |
Kerry Donovan | Communications Manager | N/A | N/A | N/A |
Paul Woroniecki | Head of Quality | N/A | N/A | N/A |
Mr. Len Walker | Head of Cultivation at Mangaoporo | N/A | N/A | N/A |
Mr. John Sanders | Chief of Sales & Marketing of Australia | N/A | N/A | N/A |
Rua Bioscience Limited engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally. It offers cannabinoid derived medicines. The company was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. Rua Bioscience Limited was founded in 2016 and is based in Gisborne, New Zealand.
El ISS Governance QualityScore de Rua Bioscience Limited, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.